NO20052560L - Krystallinske fumaratsalter av N-[1-azabicyclo (2.2.2) okt-3yl] furo (2,3-C) pyridinyl-5-karboksamid samt sammensetninger og preparater derav. - Google Patents
Krystallinske fumaratsalter av N-[1-azabicyclo (2.2.2) okt-3yl] furo (2,3-C) pyridinyl-5-karboksamid samt sammensetninger og preparater derav.Info
- Publication number
- NO20052560L NO20052560L NO20052560A NO20052560A NO20052560L NO 20052560 L NO20052560 L NO 20052560L NO 20052560 A NO20052560 A NO 20052560A NO 20052560 A NO20052560 A NO 20052560A NO 20052560 L NO20052560 L NO 20052560L
- Authority
- NO
- Norway
- Prior art keywords
- furo
- azabicyclo
- carboxamide
- oct
- preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43161902P | 2002-12-06 | 2002-12-06 | |
| PCT/IB2003/005607 WO2004052894A1 (en) | 2002-12-06 | 2003-12-01 | Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052560D0 NO20052560D0 (no) | 2005-05-26 |
| NO20052560L true NO20052560L (no) | 2005-08-17 |
Family
ID=32507764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052560A NO20052560L (no) | 2002-12-06 | 2005-05-26 | Krystallinske fumaratsalter av N-[1-azabicyclo (2.2.2) okt-3yl] furo (2,3-C) pyridinyl-5-karboksamid samt sammensetninger og preparater derav. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050165047A1 (ru) |
| EP (1) | EP1572700A1 (ru) |
| JP (1) | JP2006510664A (ru) |
| KR (1) | KR20050087826A (ru) |
| CN (1) | CN1720248A (ru) |
| AR (1) | AR042295A1 (ru) |
| AU (1) | AU2003302911A1 (ru) |
| BR (1) | BR0317019A (ru) |
| CA (1) | CA2506529A1 (ru) |
| CR (1) | CR7859A (ru) |
| EA (1) | EA200500738A1 (ru) |
| EC (1) | ECSP055834A (ru) |
| HR (1) | HRP20050494A2 (ru) |
| IS (1) | IS7844A (ru) |
| MA (1) | MA27604A1 (ru) |
| MX (1) | MXPA05005943A (ru) |
| NO (1) | NO20052560L (ru) |
| OA (1) | OA12968A (ru) |
| PL (1) | PL377052A1 (ru) |
| TW (1) | TW200427691A (ru) |
| WO (1) | WO2004052894A1 (ru) |
| ZA (1) | ZA200503988B (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6670178B1 (en) | 1992-07-10 | 2003-12-30 | Transkaryotic Therapies, Inc. | In Vivo production and delivery of insulinotropin for gene therapy |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| EP1603585A2 (en) | 2003-03-14 | 2005-12-14 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
| US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
| CN101977628A (zh) * | 2008-02-13 | 2011-02-16 | 塔加西普特公司 | α7烟碱激动剂和抗精神病药的组合 |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| ES2649539T3 (es) | 2010-05-17 | 2018-01-12 | Forum Pharmaceuticals Inc. | Formulaciones farmacéuticas que comprenden formas cristalinas de clorhidrato de (R)-7-cloro-N-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado |
| EP2846796A4 (en) | 2012-05-08 | 2015-10-21 | Forum Pharmaceuticals Inc | METHODS OF MAINTAINING, PROCESSING OR ENHANCING COGNITIVE FUNCTION |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3752373T2 (de) * | 1986-10-13 | 2004-03-25 | Asahi Kasei Kogyo K.K. | Pyridin-derivate |
| AR036040A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
-
2003
- 2003-12-01 AU AU2003302911A patent/AU2003302911A1/en not_active Abandoned
- 2003-12-01 EP EP03812627A patent/EP1572700A1/en not_active Withdrawn
- 2003-12-01 BR BR0317019-5A patent/BR0317019A/pt unknown
- 2003-12-01 OA OA1200500173A patent/OA12968A/en unknown
- 2003-12-01 WO PCT/IB2003/005607 patent/WO2004052894A1/en not_active Application Discontinuation
- 2003-12-01 MX MXPA05005943A patent/MXPA05005943A/es not_active Application Discontinuation
- 2003-12-01 PL PL377052A patent/PL377052A1/pl not_active Application Discontinuation
- 2003-12-01 CA CA002506529A patent/CA2506529A1/en not_active Abandoned
- 2003-12-01 EA EA200500738A patent/EA200500738A1/ru unknown
- 2003-12-01 KR KR1020057010196A patent/KR20050087826A/ko not_active Application Discontinuation
- 2003-12-01 CN CNA200380105166XA patent/CN1720248A/zh active Pending
- 2003-12-01 JP JP2004558940A patent/JP2006510664A/ja active Pending
- 2003-12-04 AR ARP030104471A patent/AR042295A1/es unknown
- 2003-12-05 TW TW092134360A patent/TW200427691A/zh unknown
-
2004
- 2004-10-08 US US10/962,071 patent/US20050165047A1/en not_active Abandoned
-
2005
- 2005-05-12 IS IS7844A patent/IS7844A/is unknown
- 2005-05-17 ZA ZA200503988A patent/ZA200503988B/en unknown
- 2005-05-26 NO NO20052560A patent/NO20052560L/no not_active Application Discontinuation
- 2005-06-02 HR HR20050494A patent/HRP20050494A2/hr not_active Application Discontinuation
- 2005-06-03 EC EC2005005834A patent/ECSP055834A/es unknown
- 2005-06-06 CR CR7859A patent/CR7859A/es not_active Application Discontinuation
- 2005-06-06 MA MA28315A patent/MA27604A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS7844A (is) | 2005-05-12 |
| US20050165047A1 (en) | 2005-07-28 |
| BR0317019A (pt) | 2005-10-25 |
| MA27604A1 (fr) | 2005-11-01 |
| JP2006510664A (ja) | 2006-03-30 |
| EP1572700A1 (en) | 2005-09-14 |
| CR7859A (es) | 2005-07-08 |
| WO2004052894A1 (en) | 2004-06-24 |
| ECSP055834A (es) | 2005-08-11 |
| NO20052560D0 (no) | 2005-05-26 |
| TW200427691A (en) | 2004-12-16 |
| CN1720248A (zh) | 2006-01-11 |
| EA200500738A1 (ru) | 2005-12-29 |
| HRP20050494A2 (en) | 2005-10-31 |
| AR042295A1 (es) | 2005-06-15 |
| CA2506529A1 (en) | 2004-06-24 |
| ZA200503988B (en) | 2006-09-27 |
| AU2003302911A1 (en) | 2004-06-30 |
| OA12968A (en) | 2006-10-13 |
| MXPA05005943A (es) | 2005-08-18 |
| PL377052A1 (pl) | 2006-01-23 |
| KR20050087826A (ko) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052560L (no) | Krystallinske fumaratsalter av N-[1-azabicyclo (2.2.2) okt-3yl] furo (2,3-C) pyridinyl-5-karboksamid samt sammensetninger og preparater derav. | |
| NO308772B1 (no) | Sublingual eller buckal farmasoytisk blanding inneholdende trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-c]pyrrol, samt anvendelse av forbindelsen for fremstilling av farmasoytisk blanding | |
| DE69427704T2 (de) | Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane | |
| WO2003070731A3 (en) | Azabicyclic compounds for the treatment of disease | |
| IL78661A (en) | Bone targeted inhibitors of carbonic anhydrase and methods for the preparation thereof | |
| NO20052172D0 (no) | 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter | |
| GB9109972D0 (en) | Therapeutic compounds | |
| HUP0401934A2 (hu) | Enantiomerekben dúsított demetil- és didemetil- citalopram metabolitok alkalmazása depresszió és más központi idegrendszeri rendellenességek esetében | |
| DK0411615T3 (da) | 4-(N-Substitueret amino)-2-butynyl-1-urinstoffer og -thiourinstoffer og derivater deraf som centralt virkende muscariniske midler | |
| HUT52377A (en) | Process for producing pharmaceutical compositions comprising 3-substituted-2-oxindole-1-carboxamide derivatives as active ingredient | |
| ATE59295T1 (de) | Prazosin-pirbuterol-mischung zur bronchendilatation. | |
| AU3126289A (en) | 4,5,6,7-tetrahydro isothiazolo (4,5-c) pyridine derivatives | |
| GR850995B (ru) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |